Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8686)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sutton JM, Abbott DE. Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies. World J Gastroenterol 2014; 20(42): 15564-15579 [PMID: 25400440 DOI: 10.3748/wjg.v20.i42.15564] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15564.htm |
| Number | Citing Articles |
| 1 |
Véronique Vendrely, Evelyne Peuchant, Etienne Buscail, Isabelle Moranvillier, Benoit Rousseau, Aurélie Bedel, Aurélia Brillac, Hubert de Verneuil, François Moreau-Gaudry, Sandrine Dabernat. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model. Cancer Letters 2017; 390: 91 doi: 10.1016/j.canlet.2017.01.002
|
| 2 |
Meifen Chu, Tongtong Wang, Aihua Sun, Yu Chen. Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTEN. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6191
|
| 3 |
Todd Crocenzi, Benjamin Cottam, Pippa Newell, Ronald F. Wolf, Paul D. Hansen, Chet Hammill, Matthew C. Solhjem, Yue-Yun To, Amy Greathouse, Garth Tormoen, Zeljka Jutric, Kristina Young, Keith S. Bahjat, Michael J. Gough, Marka R. Crittenden. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer 2016; 4(1) doi: 10.1186/s40425-016-0149-6
|
| 4 |
Shivang Dhoundiyal, Md. Aftab Alam. Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic
Cancer using Nanotechnology. Current Cancer Drug Targets 2023; 23(9): 697 doi: 10.2174/1568009623666230329085618
|
| 5 |
Ethan Song, Daniel Segarra, Kujtim Latifi, Susan Leuthold, Dalila Belinc, Luis Pena, Mokenge P. Malafa, Jessica M. Frakes, Sarah E. Hoffe. Recognition of Tumor Invasion of a Pancreatic Head Biliary Stent During Stereotactic Body Radiation Therapy. Practical Radiation Oncology 2019; 9(3): 132 doi: 10.1016/j.prro.2019.01.008
|
| 6 |
Masayuki Sho, Takahiro Akahori, Toshihiro Tanaka, Shoichi Kinoshita, Minako Nagai, Tetsuro Tamamoto, Chiho Ohbayashi, Masatoshi Hasegawa, Kimihiko Kichikawa, Yoshiyuki Nakajima. Importance of resectability status in neoadjuvant treatment for pancreatic cancer. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(7): 563 doi: 10.1002/jhbp.258
|
| 7 |
Brent T. Xia, David A. Habib, Vikrom K. Dhar, Nick C. Levinsky, Young Kim, Dennis J. Hanseman, Jeffrey M. Sutton, Gregory C. Wilson, Milton Smith, Kyuran Ann Choe, Jeffrey J. Sussman, Syed A. Ahmad, Daniel E. Abbott. Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. Annals of Surgical Oncology 2016; 23(13): 4156 doi: 10.1245/s10434-016-5457-z
|
| 8 |
Sameer H. Patel, Matthew H. G. Katz, Syed A. Ahmad. The Landmark Series: Preoperative Therapy for Pancreatic Cancer. Annals of Surgical Oncology 2021; 28(8): 4104 doi: 10.1245/s10434-021-10075-1
|
| 9 |
Cheng-Jeng Tai, Ming-Te Huang, Chih-Hsiung Wu, Chien-Kai Wang, Chen-Jei Tai, Chun-Chao Chang, Cheng-I. Hsieh, Yu-Jia Chang, Chang-Jer Wu, Li-Jen Kuo, Po-Lei Wei, Ray-Jade Chen, Hung-Yi Chiou. Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. Medicine 2016; 95(15): e3259 doi: 10.1097/MD.0000000000003259
|
| 10 |
Satoshi Okubo, Motohiro Kojima, Yoko Matsuda, Masayoshi Hioki, Yasuhiro Shimizu, Hirochika Toyama, Soichiro Morinaga, Naoto Gotohda, Katsuhiko Uesaka, Genichiro Ishii, Mari Mino-Kenudson, Shinichiro Takahashi. Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53801-2
|
| 11 |
Catherine M. Sielaff, Shaker A. Mousa. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology. Journal of Cancer Research and Clinical Oncology 2018; 144(7): 1205 doi: 10.1007/s00432-018-2651-3
|
| 12 |
Sanguine Byun, Seung Ho Shin, Eunjung Lee, Jihoon Lee, Sung-Young Lee, Lee Farrand, Sung Keun Jung, Yong-Yeon Cho, Soo-Jong Um, Hong-Sig Sin, Youn-Ja Kwon, Chengjuan Zhang, Benjamin K. Tsang, Ann M. Bode, Hyong Joo Lee, Ki Won Lee, Zigang Dong. The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1. Carcinogenesis 2015; : bgv148 doi: 10.1093/carcin/bgv148
|
| 13 |
Kentaro Miyake, Ryutaro Mori, Yuki Homma, Ryusei Matsuyama, Akiko Okayama, Takashi Murakami, Hisashi Hirano, Itaru Endo. MZB1 in borderline resectable pancreatic cancer resected after neoadjuvant chemoradiotherapy. Journal of Surgical Research 2017; 220: 391 doi: 10.1016/j.jss.2017.07.003
|
| 14 |
Christian Caglevic Medina, Sergio Panay Serra, Carlos Gallardo Araneda A, Jaime Anabalon Toha, Elizabeth Milla Ramirez, Mauricio Mahave Caceres. Advances in Pancreatic Cancer. 2018; doi: 10.5772/intechopen.75739
|
| 15 |
Gregory C. Wilson, Sameer H. Patel, Syed A. Ahmad. Updates on Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma. Advances in Oncology 2022; 2(1): 35 doi: 10.1016/j.yao.2022.01.003
|
| 16 |
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1427802
|
| 17 |
Nicolò Pecorelli, Sara Nobile, Stefano Partelli, Luca Cardinali, Stefano Crippa, Gianpaolo Balzano, Luigi Beretta, Massimo Falconi. Enhanced recovery pathways in pancreatic surgery: State of the art. World Journal of Gastroenterology 2016; 22(28): 6456-6468 doi: 10.3748/wjg.v22.i28.6456
|
| 18 |
Renu K. Virk, Roberto Gamez, Swati Mehrotra, Mohammed Atieh, Güliz A. Barkan, Eva M. Wojcik, Stefan E. Pambuccian. Variation of cytopathologists' use of the indeterminate diagnostic categories “atypical” and “suspicious for malignancy” in the cytologic diagnosis of solid pancreatic lesions on endoscopic ultrasound‐guided fine‐needle aspirates. Diagnostic Cytopathology 2017; 45(1): 3 doi: 10.1002/dc.23565
|
| 19 |
Sivesh K. Kamarajah, James R. Bundred, Charles Boyle, June Oo, Sanjay Pandanaboyana, Benjamin Loveday. Impact of neoadjuvant therapy on post‐operative pancreatic fistula: a systematic review and meta‐analysis. ANZ Journal of Surgery 2020; 90(11): 2201 doi: 10.1111/ans.15885
|
| 20 |
Matthew R Zeiderman, Desiree E. Morgan, John D. Christein, William E. Grizzle, Kelly M. McMasters, Lacey R. McNally. Acidic pH-Targeted Chitosan-Capped Mesoporous Silica Coated Gold Nanorods Facilitate Detection of Pancreatic Tumors via Multispectral Optoacoustic Tomography. ACS Biomaterials Science & Engineering 2016; 2(7): 1108 doi: 10.1021/acsbiomaterials.6b00111
|
| 21 |
Philipp Nitschke, Andreas Volk, Thilo Welsch, Jonas Hackl, Christoph Reissfelder, Mohammad Rahbari, Marius Distler, Hans-Detlev Saeger, Jürgen Weitz, Nuh N. Rahbari. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer. Annals of Surgery 2017; 265(6): 1219 doi: 10.1097/SLA.0000000000001808
|
| 22 |
Nicolò Pecorelli, Giovanni Capretti, Marta Sandini, Anna Damascelli, Giulia Cristel, Francesco De Cobelli, Luca Gianotti, Alessandro Zerbi, Marco Braga. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study. Annals of Surgical Oncology 2018; 25(1): 308 doi: 10.1245/s10434-017-6216-5
|
| 23 |
Iván A. González, Liang-I Kang, Gregory A. Williams, Jingxia Liu, David G. DeNardo, William G. Hawkins, Deyali Chatterjee. Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor. American Journal of Surgical Pathology 2020; 44(6): 817 doi: 10.1097/PAS.0000000000001454
|
| 24 |
Shikha Gulati, Sanjay Kumar, Parinita Singh, Anchita Diwan, Ayush Mongia. Handbook of Polymer and Ceramic Nanotechnology. 2020; : 1 doi: 10.1007/978-3-030-10614-0_56-1
|
| 25 |
Shikha Gulati, Sanjay Kumar, Parinita Singh, Anchita Diwan, Ayush Mongia. Handbook of Polymer and Ceramic Nanotechnology. 2021; : 811 doi: 10.1007/978-3-030-40513-7_56
|
| 26 |
Jordan M. Cloyd, Matthew H.G. Katz, Laura Prakash, Gauri R. Varadhachary, Robert A. Wolff, Rachna T. Shroff, Milind Javle, David Fogelman, Michael Overman, Christopher H. Crane, Eugene J. Koay, Prajnan Das, Sunil Krishnan, Bruce D. Minsky, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, William Ross, Priya Bhosale, Eric P. Tamm, Huamin Wang, Anirban Maitra, Michael P. Kim, Thomas A. Aloia, Jean-Nicholas Vauthey, Jason B. Fleming, James L. Abbruzzese, Peter W.T. Pisters, Douglas B. Evans, Jeffrey E. Lee. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. Journal of Gastrointestinal Surgery 2017; 21(1): 164 doi: 10.1007/s11605-016-3265-1
|
| 27 |
Jong-chan Lee, Soyeon Ahn, Kyu-hyun Paik, Hyoung Woo Kim, Jingu Kang, Jaihwan Kim, Jin-Hyeok Hwang. Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol. BMJ Open 2016; 6(3): e010491 doi: 10.1136/bmjopen-2015-010491
|
| 28 |
Kathleen K. Christians, Jonathan W. Heimler, Ben George, Paul S. Ritch, Beth A. Erickson, Fabian Johnston, Parag P. Tolat, William D. Foley, Douglas B. Evans, Susan Tsai. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Surgery 2016; 159(3): 893 doi: 10.1016/j.surg.2015.09.018
|
| 29 |
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancer. Biomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
|
| 30 |
Alexander V. Fisher, Daniel E. Abbott, Sara Fernandes-Taylor, Jeffrey A. Havlena, Xing Wang, Ying Shan, Elise H. Lawson, Emily R. Winslow, Sharon M. Weber, Jessica R. Schumacher. Cohort Study of Overutilization of Preventive Screening for Patients With Pancreatic Cancer. Pancreas 2018; 47(9): e65 doi: 10.1097/MPA.0000000000001131
|
| 31 |
John R. Bergquist, Carlos A. Puig, Christopher R. Shubert, Ryan T. Groeschl, Elizabeth B. Habermann, Michael L. Kendrick, David M. Nagorney, Rory L. Smoot, Michael B. Farnell, Mark J. Truty. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study. Journal of the American College of Surgeons 2016; 223(1): 52 doi: 10.1016/j.jamcollsurg.2016.02.009
|
| 32 |
Youyao Xu, Yizhen Chen, Fang Han, Jia Wu, Yuhua Zhang. Neoadjuvant therapy <i>vs</i>. upfront surgery for resectable pancreatic cancer: An update on a systematic review and meta-analysis. BioScience Trends 2021; 15(6): 365 doi: 10.5582/bst.2021.01459
|
| 33 |
Sheikh Hasibur Rahman, Robin Urquhart, Michele Molinari. Neoadjuvant therapy for resectable pancreatic cancer. World Journal of Gastrointestinal Oncology 2017; 9(12): 457-465 doi: 10.4251/wjgo.v9.i12.457
|
| 34 |
Shin Hye Hwang, Mi-Suk Park. Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma. Journal of the Korean Society of Radiology 2021; 82(2): 315 doi: 10.3348/jksr.2021.0019
|